Growth hormone and health policy.
Where this comes from
- Record sourced from PubMed, PMID 20427500.
- Also identified by DOI 10.1210/jc.2009-2688 and PMC identifier 2928896.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GH treatment for short children is representative of many frontline issues in health care policy. In this paper, we highlight key policy issues exemplified by GH, focusing on pharmaceutical innovation, insurance coverage and pricing, and physician decisions, and we discuss their implications for endocrinology and GH use.
Medical subject headings
- Growth Disorders
- Health Policy
- Human Growth Hormone
- Recombinant Proteins